Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in Japan.

about

Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in Japan.

Item

http://www.wikidata.org/entity/Q36439472

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Prospective phase II study of ...... all cell lung cancer in Japan.

@ast

Prospective phase II study of ...... all cell lung cancer in Japan.

@en

type

Item

label

Prospective phase II study of ...... all cell lung cancer in Japan.

@ast

Prospective phase II study of ...... all cell lung cancer in Japan.

@en

prefLabel

Prospective phase II study of ...... all cell lung cancer in Japan.

@ast

Prospective phase II study of ...... all cell lung cancer in Japan.

@en

P1476

Prospective phase II study of ...... all cell lung cancer in Japan.

@en

P2093

Akihiro Tamiya

http://www.w3.org/2001/XMLSchema#string

Aya Hirooka

http://www.w3.org/2001/XMLSchema#string

Hidekazu Suzuki

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Asami

http://www.w3.org/2001/XMLSchema#string

Keiko Nakao

http://www.w3.org/2001/XMLSchema#string

Kyoichi Okishio

http://www.w3.org/2001/XMLSchema#string

Masaaki Kawahara

http://www.w3.org/2001/XMLSchema#string

Motohiro Tamiya

http://www.w3.org/2001/XMLSchema#string

Naoki Omachi

http://www.w3.org/2001/XMLSchema#string

Shinji Atagi

http://www.w3.org/2001/XMLSchema#string

P2860

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer

Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Lung cancer

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.

Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group.

Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of r

P304

289-296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1759-7714.12091

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264654155

http://www.w3.org/2001/XMLSchema#string

P698

26767015

http://www.w3.org/2001/XMLSchema#string

P932

4704346

http://www.w3.org/2001/XMLSchema#string